The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 25, 2021

Filed:

Mar. 16, 2018
Applicant:

Blaze Bioscience, Inc., Seattle, WA (US);

Inventors:

Julia E. Novak, Sequim, WA (US);

Natalie Winblade Nairn, Seattle, WA (US);

Dennis M. Miller, Woodinville, WA (US);

Scott Presnell, Tacoma, WA (US);

Claudia Jochheim, Seattle, WA (US);

Mark Stroud, Seattle, WA (US);

Assignee:

Blaze Bioscience, Inc., Seattle, WA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/00 (2006.01); A61K 47/64 (2017.01); A61K 47/65 (2017.01); A61P 19/02 (2006.01); A61P 13/12 (2006.01); A61B 5/00 (2006.01); A61B 6/03 (2006.01); A61B 6/00 (2006.01); A61K 49/00 (2006.01); A61K 51/08 (2006.01); C07K 14/435 (2006.01); C07K 14/47 (2006.01); C07K 16/24 (2006.01); A61B 5/055 (2006.01); A61B 8/08 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6415 (2017.08); A61B 5/0071 (2013.01); A61B 6/037 (2013.01); A61B 6/4057 (2013.01); A61B 6/481 (2013.01); A61K 47/65 (2017.08); A61K 49/0056 (2013.01); A61K 49/0058 (2013.01); A61K 51/08 (2013.01); A61P 13/12 (2018.01); A61P 19/02 (2018.01); C07K 14/43518 (2013.01); C07K 14/43522 (2013.01); C07K 14/4726 (2013.01); C07K 16/244 (2013.01); C07K 16/248 (2013.01); A61B 5/055 (2013.01); A61B 8/481 (2013.01); A61B 2505/05 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01); C07K 2319/50 (2013.01);
Abstract

Peptides that home, target, migrate to, are directed to, are retained by, or accumulate in and/or bind to the cartilage or kidney of a subject are disclosed. Pharmaceutical compositions and uses for peptides or peptide-active agent complexes comprising such peptides are also disclosed. Such compositions can be formulated for targeted delivery of an active agent to a target region, tissue, structure or cell in the cartilage. Targeted compositions of the disclosure can deliver peptide or peptide-active agent complexes to target regions, tissues, structures, or cells targeted by the peptide.


Find Patent Forward Citations

Loading…